Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)
NCT02875652 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800
Last updated 2024-01-31
Summary
Quantification and follow-up during 3 years of circulating tumoral DNA in patients with choroidal melanoma
Conditions
- Choroidal Melanoma
Interventions
- BIOLOGICAL
-
Blood sampling
3 vials of 7,5 ml of peripherical blood will be collected at each blood sample.
Sponsors & Collaborators
-
Institut Curie
lead OTHER
Principal Investigators
-
Laurence Desjardins, MD · Institut Curie
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-21
- Primary Completion
- 2019-04-02
- Completion
- 2019-04-02
Countries
- France
Study Locations
More Related Trials
-
The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
NCT06765850 ·Status: RECRUITING
-
Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting
NCT05079113 ·Status: COMPLETED
-
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance
NCT06653127 ·Status: RECRUITING
-
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
NCT04354064 ·Status: RECRUITING
-
A Prospective Natural History Study in Uveal Melanoma
NCT04588662 ·Status: ACTIVE_NOT_RECRUITING
-
Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy
NCT02133222 ·Status: COMPLETED ·Phase: NA
-
Understanding the Transition from Normal Melanocytes to Nevus to Melanoma
NCT06605417 ·Status: RECRUITING
-
Molecular Characterization of Advanced Stage Melanoma by Blood Sampling
NCT02862743 ·Status: COMPLETED ·Phase: NA
-
Cell-free Circulating DNA in Primary Cutaneous Lymphomas
NCT02883517 ·Status: COMPLETED
-
Metabolic Phenotypes in Melanoma
NCT05570227 ·Status: RECRUITING ·Phase: NA
-
Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma
NCT06863870 ·Status: ACTIVE_NOT_RECRUITING
-
CtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent (NLG-PCNSL-01)
NCT06755619 ·Status: RECRUITING
-
ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
NCT05630131 ·Status: COMPLETED
-
Sample Collection Study in Patients With Suspected Melanoma Utilizing DermTech's Non-invasive Adhesive Patch Biopsy Kits
NCT04550000 ·Status: COMPLETED
-
Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma
NCT02251314 ·Status: COMPLETED
-
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
NCT06653062 ·Status: RECRUITING
-
Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA
NCT04104633 ·Status: COMPLETED ·Phase: NA
-
ctDNA Methylation Sequencing for Myeloma
NCT05578625 ·Status: UNKNOWN
-
Use of Ctdna in Patients With Gastrointestinal Tract Tumors
NCT06202131 ·Status: RECRUITING
-
Validation of a Molecular Prognostic Test for Eye Melanoma
NCT00406120 ·Status: WITHDRAWN
-
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
NCT07151118 ·Status: RECRUITING
-
Biology and Genetics of Smouldering Myeloma
NCT05047107 ·Status: UNKNOWN
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
NCT04835675 ·Status: COMPLETED
-
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
NCT07142226 ·Status: RECRUITING
-
The Role of Genetic Mutations and of Circulating mRNAs in Uveal Melanoma
NCT05179174 ·Status: UNKNOWN